CPI and Owen Mumford aim to help NHS hit net-zero targets
The new project aims to make the manufacturing of medical drug injection devices significantly more sustainable, helping the NHS hit net-zero targets.
Feb 19 2025
Revolutionary RNA vaccines technology could bring humanity one step closer to global vaccine equity
TheraPHIX™ enables ambient RNA vaccine storage, transforming global access by overcoming cold-chain challenges with CPI’s cutting-edge expertise.
Jan 27 2025
CPI signs MoU with Scottish Enterprise
CPI and Scottish Enterprise have agreed to formalise a shared ambition to help Scotland be a place for companies in key technology sectors to thrive.
Dec 17 2024
Scotland’s First Minister breaks ground on the UK’s Oligonucleotide Manufacturing Innovation Centre
The UK strengthens its global leadership in healthcare innovation through the establishment of the Oligonucleotide Manufacturing Innovation Centre.
Dec 16 2024
Transatlantic scientists to transition traditional vaccine development onto rapid-response platform for faster outbreak control
CEPI is providing £2.16m to CPI for a proof-of-concept study to develop the University of Toronto’s self-contained MANGO (MANufacturing on the GO) device.
Dec 11 2024
CPI-backed investment fund launches to support high-growth UK SMEs
EverQuest Capital Partners, an investment firm, launched today and announced its strategic partnership with CPI.
Nov 12 2024
UK-India critical minerals partnership gains momentum with groundbreaking collaboration
CPI and the Institute for Manufacturing collaborate with partners in a UK-India initiative to enhance innovation within the critical minerals sector.
Oct 28 2024
‘Living Lab’ set to bolster UK-India effort to decarbonise pharmaceutical industry
This collaboration could reduce the pharmaceutical industry’s emissions by up to 80% by adopting innovative manufacturing approaches.
Oct 16 2024
New £5 million accelerator programme to support UK MedTech innovation
The programme will provide up to 140 MedTech SMEs with a grant of up to £30,000 to tackle key regulatory challenges.
